Else Nutrn Hldg (OTCMKTS:BABYF – Get Free Report) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totaling 180,903 shares, a growth of 82.5% from the April 15th total of 99,117 shares. Based on an average trading volume of 137,623 shares, the short-interest ratio is currently 1.3 days. Approximately 0.4% of the company’s stock are short sold.
Else Nutrn Price Performance
OTCMKTS:BABYF opened at $0.03 on Monday. Else Nutrn has a one year low of $0.02 and a one year high of $0.80. The company’s 50-day simple moving average is $0.04 and its 200 day simple moving average is $0.07. The firm has a market capitalization of $1.55 million, a P/E ratio of -0.05 and a beta of 0.78.
Else Nutrn (OTCMKTS:BABYF – Get Free Report) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.03) EPS for the quarter.
About Else Nutrn
Else Nutrition Holdings Inc is a plant-based infant and toddler nutrition company that develops dairy-free, soy-free and gluten-free formula powders under its flagship ELSE brand. The company’s core product line includes Stage 1 infant formula and Stage 3 toddler nutrition powders formulated with a proprietary blend of almond, buckwheat and tapioca ingredients designed to mimic the nutritional profile of traditional milkābased formulas. These products are non-GMO and aim to address food sensitivities and allergen concerns in early childhood nutrition.
Founded in 2019 and headquartered in Tel Aviv, Israel, Else Nutrition began commercial sales in 2021 with initial distribution in Canada and Israel.
Further Reading
- Five stocks we like better than Else Nutrn
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Else Nutrn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Else Nutrn and related companies with MarketBeat.com's FREE daily email newsletter.
